Xaira Therapeutics

Private

South San Francisco, CaliforniaHealthcare & Life Scienceshttps://xairatherapeutics.com/

Last Round

VC Round

Apr 23, 2024

Company Overview

Xaira Therapeutics is a biotechnology company that is developing an AI-enabled platform for drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Foundation

Keywords

AI drug discoveryAI biotechdrug discovery platformbiological foundation modelstherapeutic pipelineprotein designundruggable targetsantibody therapeuticsgenerative AI for biologycomputational biologyRFdiffusion

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xaira Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Xaira Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Xaira Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Apr 23, 2024

View all Funding Rounds

Xaira Therapeutics Investors

Notable investors and investment history

Xaira Therapeutics investors
Investor	Rounds
SV Angel	VC Round
ARCH Venture Partners	VC Round
Parker Institute for Cancer Immunotherapy	VC Round
Lux Capital	VC Round
Two Sigma Ventures	VC Round
Byers Capital	VC Round
Sequoia Capital	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 23, 2024
$1.0B round led by ARCH Venture Partners and Foresite Labs.

View all signals

Xaira Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Xaira Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Xaira Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California

Year Founded2023

Last FundingApr 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.